Kazuto Ueda, MD, PhD
Pediatrician and Neonatology Specialist
Professional Information
Biography
Dr. Kazuto Ueda is a neonatology specialist at the Maternal and Neonatal Care Center of Nagoya University Hospital. He is highly experienced in the treatment of critically ill newborns and infants requiring intensive care in the NICU. In addition to his clinical work, he facilitates palliative care education programs for pediatricians in Japan and actively participates in pediatric hospice activities within the local community. Areas of Expertise: - Neonatal intensive care and follow-up of premature infants - Perinatal hypoxic-ischemic encephalopathy (HIE) - Fetal growth restriction and neurodevelopmental disorders - Stem cell therapies and regenerative medicine - Palliative care practices in neonatology
Specialization
Neonatal intensive care and follow-up of premature infants
Research & Publications
"Characteristics of neonatal-onset and presumed neonatal arterial ischemic stroke" Compares clinical and radiological features of neonatal-onset versus presumed neonatal arterial ischemic stroke. "Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial)" Evaluates the safety and tolerability of a Muse cell-based product in newborns with HIE treated with therapeutic hypothermia. "Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy" Investigates the effect of intravenously administered Muse cells in reducing glutamate toxicity and inflammation in experimental perinatal HIE. "Mesenchymal stem/stromal cells stably transduced with an inhibitor of CC chemokine ligand 2 ameliorate bronchopulmonary dysplasia and pulmonary hypertension" Studies the potential of genetically modified mesenchymal stem cells to treat BPD and pulmonary hypertension. "Establishment of a Novel Fetal Growth Restriction Model and Development of a Stem-Cell Therapy Using Umbilical Cord-Derived Mesenchymal Stromal Cells" Describes the creation of a new model for fetal growth restriction and the development of a stem cell therapy using umbilical cord-derived MSCs.